Viewing Study NCT06613594



Ignite Creation Date: 2024-10-26 @ 3:41 PM
Last Modification Date: 2024-10-26 @ 3:41 PM
Study NCT ID: NCT06613594
Status: RECRUITING
Last Update Posted: None
First Post: 2024-09-23

Brief Title: Effects of Kaltenborn Translatoric Glides As Compared to Traction Mobilization in the Management of Frozen Shoulder
Sponsor: None
Organization: None

Study Overview

Official Title: Effects of Kaltenborn Translatoric Glides As Compared to Traction Mobilization in the Management of Frozen Shoulder
Status: RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Frozen shoulder is a common musculoskeletal condition Painful gradual loss of both active and passive gleno-humeral motion resulting from progressive fibrosis and ultimate contracture of the gleno-humeral joint capsuleRange of motions and capsular pattern affected in frozen shoulder Physiotherapists have a wide range of options in managing frozen shoulder including Electrotherapeutic modalities kaltenborn mobilization Maitlands mobilizationMulligans mobilization and Manipulation So far studies have shown the efficacy of different treatments in combination or in isolationsome studies on Kaltenborn mobilization but no obseved comparative effects of Kaltenborn mobilization ie translatoric glides and traction mobilzation in patients with frozen shoulderIn clinically both techniques of kaltenborn are used but there is no evidence regarding which one is more effective If found effectivethis study can help to use best clinical treatment in the managemnent of frozen shoulder
Detailed Description: Frozen shoulder is a common MSK condition with an insidious onset accompanied by stiffness and trouble sleeping on the affected sideThis condition effects General population 2-5 globally diabetics 10-20 Women have a significantly higher incidence males 70 of cases are femalefrozen shoulder is a painful gradual loss of both active and passive gleno-humeral motion resulting from progressive fibrosis and ultimate contracture of the gleno-humeral joint capsule

The capsule in frozen shoulder tightensthickness and adheres to bone it causes severe limiting of both osteikinetics and arthrokinetics shoulder range of motionresulting in long term functional disabilityAs the capsule thickens mobility limitations occurs in capsular patternKalternborn traction mobilization helpful in breaking capsular adhesions and decreasein severe pain Improving shoulder limitation such as external roation abduction and internal rotation kaltnborn translatoric glides effective

These mobilization changes the relative capsular adhesions and reduce stress on Gleno-humeral joint

In clinically both techniques of kaltnborn joint mobilization are used but there is no evidence which one is more effective in the management of frozen shoulder

Hence the current study will investigate the effects of Kaltenborn linear tranlatoric glides as compared to traction mobilization mobilization on shoulder range of motion and pain in patients with adhesive capsulitis

This study includes Subjects with nonspecific adhesive capsulitis without specific identifiable etiology ie infection inflammatory disease 40-65 years of age both males and females and chronic shoulder pain 3 monthspositive capsular patternThe selection of subjects will be using non-probability purposive sampling techniqueParticipants will be randomized using sealed envelope method and allocated to one of the 3 groups

The data collection tools for pain is VAS for ROM goniometer is used for FEAR used fear avoidance belief questionnaire and for functional disablity is SPADI

The time duration for treatment protocol is total of 10 sessions 5 sessions per week for 2 consecutive weeks for approximately 25-30 mins

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None